Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273891 | 12527389 | 1 | I | 2016 | 20160621 | 20160705 | 20160705 | EXP | US-PFIZER INC-2016313334 | PFIZER | 35.00 | YR | M | Y | 160.00000 | KG | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273891 | 12527389 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | UNK (3 G/M2 Q 12H X 12 DOSES) | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 4 | SS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 5 | SS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 6 | SS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 72168 | SOLUTION FOR INJECTION | |||||||||
| 125273891 | 12527389 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | U | 0 | ||||||||||
| 125273891 | 12527389 | 8 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 125273891 | 12527389 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, 3X/DAY | 0 | 100 | MG | CAPSULE | TID | ||||||
| 125273891 | 12527389 | 10 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | TABLET | QD | ||||||
| 125273891 | 12527389 | 11 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 10 MG, 3X/DAY | 0 | 10 | MG | TABLET | TID | ||||||
| 125273891 | 12527389 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 125273891 | 12527389 | 13 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 90 UG, AS NEEDED (FREE 90 MCG/INH INHALATION AEROSOL: 2 PUFF(S) INHALED 4 TIMES A DAY, AS NEEDED) | 0 | 90 | UG | ||||||||
| 125273891 | 12527389 | 14 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | TABLET | BID | ||||||
| 125273891 | 12527389 | 15 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Oral | 750 MG, 2X/DAY | 0 | 750 | MG | TABLET | BID | ||||||
| 125273891 | 12527389 | 16 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 125273891 | 12527389 | 17 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 50 MG, 1X/DAY (AT BEDTIME) | 0 | 50 | MG | TABLET | QD | ||||||
| 125273891 | 12527389 | 18 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 125273891 | 12527389 | 19 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID | ||||||
| 125273891 | 12527389 | 20 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 125273891 | 12527389 | 21 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | UNK | 0 | |||||||||||
| 125273891 | 12527389 | 22 | C | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
| 125273891 | 12527389 | 23 | C | NS | SODIUM CHLORIDE | 1 | 150 ML, UNK | 0 | 150 | ML | |||||||||
| 125273891 | 12527389 | 24 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 125273891 | 12527389 | 25 | C | COREG | CARVEDILOL | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | BID | ||||||||
| 125273891 | 12527389 | 26 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 125273891 | 12527389 | 27 | C | KEPPRA | LEVETIRACETAM | 1 | Oral | UNK, 2X/DAY | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125273891 | 12527389 | 1 | Acute myeloid leukaemia |
| 125273891 | 12527389 | 7 | Acute myeloid leukaemia |
| 125273891 | 12527389 | 8 | Acute myeloid leukaemia |
| 125273891 | 12527389 | 12 | Hypertension |
| 125273891 | 12527389 | 13 | Dyspnoea |
| 125273891 | 12527389 | 14 | Hypertension |
| 125273891 | 12527389 | 16 | Hypertension |
| 125273891 | 12527389 | 17 | Headache |
| 125273891 | 12527389 | 23 | Prophylaxis |
| 125273891 | 12527389 | 24 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125273891 | 12527389 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125273891 | 12527389 | Acute myeloid leukaemia | |
| 125273891 | 12527389 | Deep vein thrombosis | |
| 125273891 | 12527389 | Disease progression | |
| 125273891 | 12527389 | Escherichia bacteraemia | |
| 125273891 | 12527389 | Febrile neutropenia | |
| 125273891 | 12527389 | Hypomagnesaemia | |
| 125273891 | 12527389 | Pancytopenia | |
| 125273891 | 12527389 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125273891 | 12527389 | 1 | 20150626 | 0 | ||
| 125273891 | 12527389 | 2 | 20150926 | 0 | ||
| 125273891 | 12527389 | 3 | 20151119 | 20151124 | 0 | |
| 125273891 | 12527389 | 4 | 20151230 | 20160104 | 0 | |
| 125273891 | 12527389 | 5 | 20160211 | 20160216 | 0 | |
| 125273891 | 12527389 | 6 | 20160316 | 20160321 | 0 |